Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Ochsner Journal
|
October 11, 2012
Diagnostic and therapeutic challenges of intracranial hemorrhage in neonates with congenital hemophilia: a case report and review
Tammuella Chrisentery Singleton, Matthew Keane
Ochsner Journal
|
October 11, 2012
Diffuse pontine astrocytoma with lipocytic differentiation
Randall Craver, Christopher Arcement, Tammuella Chrisentery Singleton
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 18, 2025
The Iron Ladies: Prevalence and Risk Factors of Iron Deficiency in Females With Bleeding Disorders
Meghan McCormick, Jianzhong Hu, Martin Chandler, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 19, 2023
Long-term follow-up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma-derived factor VIII (Koate) that contains ADAMTS13
Tammuella Chrisentery-Singleton, Lisa N Boggio, Manuel D Carcao, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 19, 2023
Observational cohort study of long-term outcomes of liver transplantation in haemophilia
Margaret V Ragni, Jessica Callis, Nabil Daoud, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 16, 2024
Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors
Amy Dunn, Yesim Dargaud, Yasmina Abajas, et al.
Blood Vessels, Thrombosis & Hemostasis
|
July 1, 2026
Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 study
Tammuella Chrisentery-Singleton, Suchitra Acharya, Sanjay Ahuja, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 27, 2022
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors
Steven W Pipe, Cédric Hermans, Meera Chitlur, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Ochsner Journal
|
October 11, 2012
Diagnostic and therapeutic challenges of intracranial hemorrhage in neonates with congenital hemophilia: a case report and review
Tammuella Chrisentery Singleton, Matthew Keane
Ochsner Journal
|
October 11, 2012
Diffuse pontine astrocytoma with lipocytic differentiation
Randall Craver, Christopher Arcement, Tammuella Chrisentery Singleton
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 18, 2025
The Iron Ladies: Prevalence and Risk Factors of Iron Deficiency in Females With Bleeding Disorders
Meghan McCormick, Jianzhong Hu, Martin Chandler, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 19, 2023
Long-term follow-up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma-derived factor VIII (Koate) that contains ADAMTS13
Tammuella Chrisentery-Singleton, Lisa N Boggio, Manuel D Carcao, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 19, 2023
Observational cohort study of long-term outcomes of liver transplantation in haemophilia
Margaret V Ragni, Jessica Callis, Nabil Daoud, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 16, 2024
Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors
Amy Dunn, Yesim Dargaud, Yasmina Abajas, et al.
Blood Vessels, Thrombosis & Hemostasis
|
July 1, 2026
Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 study
Tammuella Chrisentery-Singleton, Suchitra Acharya, Sanjay Ahuja, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 27, 2022
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors
Steven W Pipe, Cédric Hermans, Meera Chitlur, et al.
Page
of 1